{"id":"bac-treatment","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of BAC treatment involves targeting a key enzyme responsible for the progression of the disease. This enzyme inhibition leads to a reduction in the disease's symptoms and progression.","oneSentence":"BAC treatment works by inhibiting the activity of a specific enzyme.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:22:01.609Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT06620276","phase":"NA","title":"ACT_for Alcohol Use Disorder and Depression","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-05-01","conditions":"Depression - Major Depressive Disorder, Alcohol Use Disorder","enrollment":30},{"nctId":"NCT07435389","phase":"NA","title":"VENTILATION DURING SPACEFLIGHT (PHASE 2)","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Régional Metz-Thionville","startDate":"2026-03-16","conditions":"Non-invasive Ventilation","enrollment":12},{"nctId":"NCT07388823","phase":"NA","title":"Nailbed Repair for Patients With Nailbed Injuries","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-05-01","conditions":"Nail Bed Injury, Nail Place Disruption, Nail Laceration","enrollment":100},{"nctId":"NCT06264791","phase":"NA","title":"Stress-motivated Alcohol Use as a Value-based Decision-making Process","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-02-01","conditions":"Psychological Stress, Alcohol Intoxication","enrollment":160},{"nctId":"NCT00499330","phase":"PHASE3","title":"Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2007-10-12","conditions":"Lung Cancer","enrollment":701},{"nctId":"NCT04918745","phase":"NA","title":"VertiGO! - Get up and GO! With the Vestibular Implant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2021-07-01","conditions":"Bilateral Vestibular Loss","enrollment":13},{"nctId":"NCT07176208","phase":"PHASE1","title":"Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults","status":"RECRUITING","sponsor":"Food and Drug Administration (FDA)","startDate":"2025-12-29","conditions":"Cannabis, Drug Effects, Driving Performance","enrollment":48},{"nctId":"NCT03929224","phase":"PHASE4","title":"The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2018-10-25","conditions":"Skin Infection","enrollment":17},{"nctId":"NCT05249959","phase":"PHASE2","title":"Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.","status":"RECRUITING","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2022-03-21","conditions":"Relapsed Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma","enrollment":49},{"nctId":"NCT07293494","phase":"NA","title":"Neurobehavioral Changes Following Spaceflight Stressors","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-06","conditions":"Stressor, Individual, Alcohol Impairment, Sleep Deprivation","enrollment":56},{"nctId":"NCT03567876","phase":"PHASE2","title":"Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL","status":"COMPLETED","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2018-09-03","conditions":"Lymphoma, Mantle-Cell","enrollment":141},{"nctId":"NCT01946100","phase":"NA","title":"Treatment of Multifocal Lung Adenocarcinoma","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2013-11-06","conditions":"Lung Neoplasms, Carcinoma Non-small-cell Lung, Adenocarcinoma","enrollment":100},{"nctId":"NCT06788041","phase":"NA","title":"EFFECT OF HAMMAM EXPERIENCE ON GENERAL HEALTH AND PERCEIVED WELL-BEING","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2024-09-01","conditions":"Chronic Stress, Wellness, General Health","enrollment":22},{"nctId":"NCT05856994","phase":"PHASE1","title":"Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-09-19","conditions":"Burn Injury","enrollment":18},{"nctId":"NCT04931095","phase":"PHASE1","title":"The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2022-02-17","conditions":"Cannabis Intoxication, Alcohol Intoxication","enrollment":60},{"nctId":"NCT06293040","phase":"PHASE1","title":"Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-09-26","conditions":"Cannabis Intoxication, Alcohol Intoxication","enrollment":90},{"nctId":"NCT02847338","phase":"PHASE4","title":"Comparison of Optimal Hypertension Regimens","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2016-11","conditions":"Hypertension","enrollment":940},{"nctId":"NCT04131556","phase":"PHASE1","title":"A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult Participants","status":"TERMINATED","sponsor":"Shire","startDate":"2019-10-25","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT07125534","phase":"NA","title":"Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design","status":"RECRUITING","sponsor":"University of Illinois at Urbana-Champaign","startDate":"2025-08-09","conditions":"Alcohol Drinking, Alcohol Use Disorder (AUD), Alcohol Intoxication","enrollment":200},{"nctId":"NCT06340581","phase":"PHASE1","title":"A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2024-10-17","conditions":"Healthy","enrollment":""},{"nctId":"NCT06290102","phase":"PHASE1","title":"Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2024-05-16","conditions":"Asthma","enrollment":30},{"nctId":"NCT04115098","phase":"PHASE2","title":"Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-06-25","conditions":"Axial Spondyloarthritis","enrollment":42},{"nctId":"NCT05637294","phase":"NA","title":"Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome","status":"RECRUITING","sponsor":"Tampere University Hospital","startDate":"2023-02-15","conditions":"Carpal Tunnel Syndrome","enrollment":110},{"nctId":"NCT06979388","phase":"PHASE1","title":"A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-05-20","conditions":"Healthy Participants","enrollment":14},{"nctId":"NCT05087875","phase":"NA","title":"Evaluating an mHealth Intervention for Reducing Alcohol Use Among Adolescent and Young Adult Cancer Survivors","status":"COMPLETED","sponsor":"Carolyn Lauckner","startDate":"2022-11-28","conditions":"Cancer, Alcohol Use","enrollment":40},{"nctId":"NCT06165354","phase":"NA","title":"Effects of LiveSpo X-SECRET in SupportiveTreatment of Vaginitis","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2023-12-01","conditions":"Vaginitis","enrollment":120},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT05182476","phase":"PHASE2","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia","status":"TERMINATED","sponsor":"Neurocrine Biosciences","startDate":"2021-12-07","conditions":"Schizophrenia","enrollment":216},{"nctId":"NCT06205134","phase":"PHASE1, PHASE2","title":"Comparative Bioavailability of Intranasal Epinephrine","status":"COMPLETED","sponsor":"Nasus Pharma","startDate":"2023-08-22","conditions":"Anaphylaxis, Anaphylactic Reaction","enrollment":12},{"nctId":"NCT06994962","phase":"NA","title":"Multi-Component Breath Alcohol Intervention Phase 3","status":"RECRUITING","sponsor":"Northeastern University","startDate":"2025-05-01","conditions":"Alcohol Use, Alcohol Drinking, Drinking Behavior","enrollment":90},{"nctId":"NCT05927649","phase":"PHASE1","title":"A TQTc Study for Omaveloxolone","status":"COMPLETED","sponsor":"Biogen","startDate":"2023-07-11","conditions":"Health Adult Subjects","enrollment":30},{"nctId":"NCT06992453","phase":"NA","title":"Multi-omics Dissection of Gut Microbiome Engraftment During FMT","status":"NOT_YET_RECRUITING","sponsor":"Catholic University of the Sacred Heart","startDate":"2025-06-01","conditions":"Recurrent C. Difficile (rCDI), Ulcerative Colitis (UC), Metabolic Syndrome (MetS)","enrollment":90},{"nctId":"NCT04844424","phase":"PHASE1","title":"A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-04-14","conditions":"Healthy","enrollment":115},{"nctId":"NCT06736444","phase":"NA","title":"Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT)","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2025-05-30","conditions":"Insomnia, Alcohol Use, Marijuana Use","enrollment":800},{"nctId":"NCT04553042","phase":"PHASE1","title":"A Study of Seltorexant in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-14","conditions":"Healthy","enrollment":69},{"nctId":"NCT04566926","phase":"PHASE1","title":"A Study of JNJ-64140284 in Healthy Male Participants","status":"TERMINATED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2020-09-29","conditions":"Healthy","enrollment":33},{"nctId":"NCT02919579","phase":"PHASE1","title":"A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-10-07","conditions":"Depressive Disorder, Major","enrollment":27},{"nctId":"NCT05392530","phase":"PHASE1","title":"A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants","status":"COMPLETED","sponsor":"Actelion","startDate":"2022-05-25","conditions":"Healthy","enrollment":23},{"nctId":"NCT04388501","phase":"PHASE1","title":"A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2021-06-07","conditions":"Healthy","enrollment":23},{"nctId":"NCT05236231","phase":"PHASE1","title":"A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participants","status":"COMPLETED","sponsor":"Actelion","startDate":"2022-02-04","conditions":"Healthy","enrollment":40},{"nctId":"NCT04448964","phase":"PHASE1","title":"A Study of JNJ-70033093 in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-06-26","conditions":"Healthy","enrollment":24},{"nctId":"NCT04906408","phase":"NA","title":"The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2021-09-17","conditions":"Abdomen Hernia","enrollment":300},{"nctId":"NCT05578846","phase":"PHASE1","title":"Bioequivalence Between 180 mg and 60 mg ALXN2050 Tablets and Food Effect on ALXN2050 Pharmacokinetics","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2022-10-13","conditions":"Healthy Adult Participants","enrollment":42},{"nctId":"NCT03010059","phase":"PHASE1","title":"A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-02-06","conditions":"Healthy","enrollment":48},{"nctId":"NCT02608320","phase":"PHASE1","title":"A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-11-17","conditions":"Healthy","enrollment":52},{"nctId":"NCT02984852","phase":"PHASE1","title":"Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants","status":"COMPLETED","sponsor":"Janssen Scientific Affairs, LLC","startDate":"2016-12","conditions":"Healthy","enrollment":30},{"nctId":"NCT04090086","phase":"PHASE1","title":"A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-16","conditions":"Healthy","enrollment":16},{"nctId":"NCT05155007","phase":"PHASE1","title":"A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on Rilematovir","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-12-10","conditions":"Healthy","enrollment":18},{"nctId":"NCT05134350","phase":"PHASE1","title":"Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy Participants","status":"COMPLETED","sponsor":"Loxo Oncology, Inc.","startDate":"2020-02-06","conditions":"Healthy Volunteers","enrollment":10},{"nctId":"NCT05671887","phase":"","title":"DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2022-11-16","conditions":"Lung Cancer, Bilateral Cancer, Lung Transplant","enrollment":125},{"nctId":"NCT00309998","phase":"PHASE2","title":"Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2005-09","conditions":"Lung Cancer","enrollment":50},{"nctId":"NCT03037749","phase":"EARLY_PHASE1","title":"Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2015-09-27","conditions":"Domestic Violence, Alcohol Consumption","enrollment":42},{"nctId":"NCT05122143","phase":"NA","title":"Efficacy and Safety of AM-301 on Allergic Symptoms of Perennial Allergic Rhinitis Sufferers","status":"COMPLETED","sponsor":"Altamira Medica Ltd.","startDate":"2021-11-10","conditions":"Perennial Allergic Rhinitis, Rhinitis, Allergic","enrollment":37},{"nctId":"NCT03908437","phase":"PHASE4","title":"Rapid Initiation of Drug Treatment Engagement","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2019-07-15","conditions":"Opioid-use Disorder, Overdose","enrollment":104},{"nctId":"NCT06456905","phase":"NA","title":"Automated Reinforcement Management Systems, Phase II","status":"RECRUITING","sponsor":"Washington State University","startDate":"2024-06-07","conditions":"Alcohol Use Disorder","enrollment":125},{"nctId":"NCT03449095","phase":"NA","title":"Understanding Alcohol Reward in Social Context","status":"COMPLETED","sponsor":"University of Illinois at Urbana-Champaign","startDate":"2017-11-04","conditions":"Alcohol Drinking, Alcohol Use Disorder, Alcohol Intoxication","enrollment":640},{"nctId":"NCT04438174","phase":"PHASE1, PHASE2","title":"Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds","status":"TERMINATED","sponsor":"University of Utah","startDate":"2022-08","conditions":"Wounds and Injuries","enrollment":1},{"nctId":"NCT04192448","phase":"NA","title":"Men, Mood, and Attention Study: Examination of Alcohol, State Anger, and Emotion Regulation Sexual Aggression","status":"TERMINATED","sponsor":"Elizabeth C Neilson","startDate":"2020-09-01","conditions":"Alcohol Intoxication, Anger","enrollment":3},{"nctId":"NCT06427213","phase":"PHASE2","title":"This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2024-05-20","conditions":"Lymphoma, Mantle-Cell, Lymphoma, Non-Hodgkin","enrollment":41},{"nctId":"NCT03483363","phase":"PHASE4","title":"Topical Antibiotic Irrigation (Gentamicin) in Prophylaxis of Midfacial Fracture Surgical Wounds","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-10-09","conditions":"Surgical Site Infection","enrollment":39},{"nctId":"NCT06061523","phase":"PHASE1","title":"A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy Participants","status":"WITHDRAWN","sponsor":"Amgen","startDate":"2024-07-15","conditions":"Healthy Participants","enrollment":""},{"nctId":"NCT06166290","phase":"NA","title":"Comparing CO2 Laser and Electrosurgical Treatments for Perianal Condyloma","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2024-01","conditions":"Perianal Wart","enrollment":110},{"nctId":"NCT05327491","phase":"PHASE1","title":"A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets","status":"COMPLETED","sponsor":"Amgen","startDate":"2022-03-21","conditions":"Healthy Participants","enrollment":146},{"nctId":"NCT04802746","phase":"PHASE1","title":"A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2021-03-09","conditions":"Healthy Study Participants, Participants With Mild Asthma","enrollment":78},{"nctId":"NCT05854602","phase":"NA","title":"The Relative Effects of Three Parent-Intervention Components to Reduce Children's Anxiety","status":"NOT_YET_RECRUITING","sponsor":"University of Amsterdam","startDate":"2023-11","conditions":"Anxiety","enrollment":266},{"nctId":"NCT05048784","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy Participants","status":"COMPLETED","sponsor":"Amgen","startDate":"2021-08-16","conditions":"Healthy Participants","enrollment":145},{"nctId":"NCT00346320","phase":"NA","title":"Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2006-08-02","conditions":"Lung Cancer","enrollment":80},{"nctId":"NCT05319912","phase":"PHASE1","title":"A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2014-04-07","conditions":"Healthy","enrollment":18},{"nctId":"NCT05319899","phase":"PHASE1","title":"A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2014-01-20","conditions":"Healthy","enrollment":18},{"nctId":"NCT03956238","phase":"NA","title":"Alcohol Myopia, Objectification, and Sexual Assault","status":"COMPLETED","sponsor":"University of Nebraska Lincoln","startDate":"2019-04-22","conditions":"Alcoholic Intoxication","enrollment":359},{"nctId":"NCT01107626","phase":"PHASE3","title":"Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2010-10-25","conditions":"Lung Cancer","enrollment":1516},{"nctId":"NCT00080938","phase":"PHASE2","title":"Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2005-12-20","conditions":"Lung Cancer, Metastatic Cancer","enrollment":26},{"nctId":"NCT00103207","phase":"PHASE2","title":"Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2005-10-13","conditions":"Lung Cancer","enrollment":72},{"nctId":"NCT00003649","phase":"PHASE1","title":"Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1998-11-17","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT00006004","phase":"PHASE2","title":"Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2000-08-22","conditions":"Lung Cancer","enrollment":""},{"nctId":"NCT04380116","phase":"NA","title":"Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality","status":"COMPLETED","sponsor":"Yale University","startDate":"2020-06-29","conditions":"Alcohol Use Disorder","enrollment":96},{"nctId":"NCT04438655","phase":"NA","title":"Prospective Randomized Clinical Trial on Oral and Intravenous Antibiotic Prophylaxis in Colorectal Surgery.","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2019-05-01","conditions":"Colorectal Surgery","enrollment":130},{"nctId":"NCT03930524","phase":"NA","title":"Adaptive Preventive Intervention for College Alcohol Use","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-07-31","conditions":"College Student Drinking","enrollment":891},{"nctId":"NCT05783856","phase":"NA","title":"Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2020-05-03","conditions":"Sexually Transmitted Diseases","enrollment":100},{"nctId":"NCT04600505","phase":"PHASE1","title":"A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-10-19","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":47},{"nctId":"NCT04631107","phase":"PHASE2","title":"AD109 Dose Finding in Mild to Moderate OSA","status":"COMPLETED","sponsor":"Apnimed","startDate":"2020-12-22","conditions":"Obstructive Sleep Apnea","enrollment":32},{"nctId":"NCT03981783","phase":"NA","title":"Informatics Framework for Pulmonary Rehabilitation","status":"UNKNOWN","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2020-06-11","conditions":"COPD","enrollment":120},{"nctId":"NCT02357992","phase":"NA","title":"Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-04-05","conditions":"Lung Cancer","enrollment":122},{"nctId":"NCT02886494","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia","status":"COMPLETED","sponsor":"Charsire Biotechnology Corp.","startDate":"2016-12","conditions":"Alzheimer's Disease or Vascular Dementia","enrollment":80},{"nctId":"NCT02467413","phase":"PHASE2","title":"BAC in Patient With Alzheimer's Disease or Vascular Dementia","status":"WITHDRAWN","sponsor":"Charsire Biotechnology Corp.","startDate":"2017-01-30","conditions":"Alzheimer's Disease, Vascular Dementia","enrollment":""},{"nctId":"NCT00634166","phase":"PHASE4","title":"Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group","status":"TERMINATED","sponsor":"Mylan Inc.","startDate":"2007-09","conditions":"Burns","enrollment":220},{"nctId":"NCT00970684","phase":"PHASE2","title":"Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Nathan Pennell, MD, PhD","startDate":"2009-09","conditions":"Lung Cancer","enrollment":13},{"nctId":"NCT01662050","phase":"PHASE2","title":"Phase II Study of Age-Adjusted Rituximab, Bendamustine, Cytarabine as Induction Therapy in Older Patients With MCL","status":"COMPLETED","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2012-03-20","conditions":"Mantle Cell Lymphoma","enrollment":57},{"nctId":"NCT00979212","phase":"PHASE2","title":"Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2011-02","conditions":"Lung Cancer","enrollment":71},{"nctId":"NCT04944771","phase":"PHASE1","title":"Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-07-26","conditions":"Solid and Hematological Malignancies","enrollment":48},{"nctId":"NCT02809131","phase":"PHASE3","title":"Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2016-04-01","conditions":"Sick Sinus Syndrome, Complete Heart Block, Syncope","enrollment":1010},{"nctId":"NCT05329454","phase":"PHASE1","title":"To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg","status":"COMPLETED","sponsor":"Overseas Pharmaceuticals, Ltd.","startDate":"2020-12-24","conditions":"Chronic Pain","enrollment":30},{"nctId":"NCT02705404","phase":"","title":"A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2016-02-11","conditions":"Lung Neoplasms, Carcinoma Non-small-cell Lung","enrollment":8},{"nctId":"NCT02533154","phase":"PHASE4","title":"Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2015-07-27","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT04256629","phase":"PHASE1","title":"A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-03-03","conditions":"Healthy Volunteers (Intended Indication: Chronic Kidney Disease)","enrollment":24},{"nctId":"NCT02680561","phase":"PHASE1","title":"A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2016-04","conditions":"Asthma","enrollment":20},{"nctId":"NCT00000635","phase":"NA","title":"Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Herpes Simplex, HIV Infections","enrollment":25},{"nctId":"NCT04757974","phase":"PHASE1","title":"Low-dose Fostemsavir Extended Release Relative Bioavailability Study","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2021-03-05","conditions":"HIV Infections","enrollment":32},{"nctId":"NCT04969497","phase":"PHASE1","title":"Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers","status":"COMPLETED","sponsor":"Zosano Pharma Corporation","startDate":"2021-06-24","conditions":"Migraine","enrollment":48},{"nctId":"NCT00025285","phase":"PHASE2","title":"Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2001-11-01","conditions":"Lung Cancer","enrollment":46}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":117,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CSTC1-BAC"],"phase":"phase_2","status":"active","brandName":"BAC treatment","genericName":"BAC treatment","companyName":"Charsire Biotechnology Corp.","companyId":"charsire-biotechnology-corp","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BAC treatment works by inhibiting the activity of a specific enzyme. Used for Hypertension.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}